These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 8187625)

  • 1. [Secondary leukemias after etoposide chemotherapy].
    Bokemeyer C; Schmoll HJ; Poliwoda H
    Dtsch Med Wochenschr; 1994 May; 119(19):707-13. PubMed ID: 8187625
    [No Abstract]   [Full Text] [Related]  

  • 2. [Chemotherapy of small cell bronchogenic carcinoma in a patient on hemodialysis for chronic renal failure. Apropos of a case].
    Guillou B; Robinet G; Gouva S; Guillodo MP; Daniel C; Clavier J
    Rev Pneumol Clin; 1998 Sep; 54(4):215-8. PubMed ID: 9805752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Etoposide--an effective single drug for treating bronchogenic carcinoma.
    Anderson G; Peel ET; Cheong CM; Broderick NJ
    Clin Oncol; 1982; 8(3):215-8. PubMed ID: 7140048
    [No Abstract]   [Full Text] [Related]  

  • 4. Phase II clinical trial of weekly administration of VP-16-213 in small cell bronchogenic carcinoma.
    Cohen MH; Broder LE; Fossieck BE; Ihde DC; Minna JD
    Cancer Treat Rep; 1977; 61(3):489-90. PubMed ID: 194694
    [No Abstract]   [Full Text] [Related]  

  • 5. Secondary leukemias in refractory germ cell tumor patients undergoing autologous stem-cell transplantation using high-dose etoposide.
    Houck W; Abonour R; Vance G; Einhorn LH
    J Clin Oncol; 2004 Jun; 22(11):2155-8. PubMed ID: 15169802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of secondary leukemia following high cumulative doses of etoposide during chemotherapy for testicular cancer.
    Bokemeyer C; Schmoll HJ; Kuczyk MA; Beyer J; Siegert W
    J Natl Cancer Inst; 1995 Jan; 87(1):58-60. PubMed ID: 7666466
    [No Abstract]   [Full Text] [Related]  

  • 7. Phase II studies on weekly cisplatinum plus epirubicin or etoposide in the treatment of advanced non-small cell bronchogenic carcinoma.
    Lelli G; Casadio M; Giuliotti C; Giordani S; Martoni A; Strocchi E; Pannuti F
    Chemioterapia; 1986 Aug; 5(4):228-31. PubMed ID: 3021346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current status of American studies with bleomycin.
    Carter SK; Blum RH
    Prog Biochem Pharmacol; 1976; 11():158-71. PubMed ID: 63960
    [No Abstract]   [Full Text] [Related]  

  • 9. Review of etoposide.
    Phillips NC; Lauper RD
    Clin Pharm; 1983; 2(2):112-9. PubMed ID: 6309469
    [No Abstract]   [Full Text] [Related]  

  • 10. [A case of nephrotic syndrome associated with bronchogenic carcinoma].
    Tachibana A; Suzuki K; Hatakeyama S; Nagayama M; Okano H
    Nihon Kyobu Shikkan Gakkai Zasshi; 1992 Jul; 30(7):1350-4. PubMed ID: 1405114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Etoposide and cis-platinum in non-small-cell bronchogenic carcinoma.
    Klastersky J; Longeval E; Nicaise C; Weerts D
    Cancer Treat Rev; 1982 Jun; 9 Suppl():133-8. PubMed ID: 6889918
    [No Abstract]   [Full Text] [Related]  

  • 12. [Correlations between clinical pharmacodynamics and pharmacokinetics of cisplatin and etoposide].
    Desoize B; Maréchal F; Cattan A
    Ann Biol Clin (Paris); 1993; 51(2):125-8. PubMed ID: 8214810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of inoperable non-small-cell bronchogenic carcinoma with etoposide and cis-platinum.
    Mitrou PS; Fischer M; Weissenfels I; Diehl V; Gropp C; Liesenfeld A; Schmidt M; Berdel WE; Fink U; Graubner M
    Cancer Treat Rev; 1982 Jun; 9 Suppl():139-42. PubMed ID: 6889919
    [No Abstract]   [Full Text] [Related]  

  • 14. Cisplatin and etoposide combination in the treatment of bronchogenic carcinoma.
    Mazzei T; Marino C; Nozzoli F; Lopes-Pegna A; Righi R; Santomaggio C; Lamanna S; Periti P
    Chemioterapia; 1984 Feb; 3(1):16-8. PubMed ID: 6100172
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trial of vindesine, etoposide, and cisplatin in patients with previously treated, advanced-stage, non-small cell bronchogenic carcinoma.
    Albain KS; Bitran JD; Golomb HM; Hoffman PC; DeMeester TR; Skosey C; Noble S; Blough RR
    Cancer Treat Rep; 1984 Feb; 68(2):413-5. PubMed ID: 6538114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Chemotherapy in non-small cell bronchial carcinoma. 12 years' experience in an international cooperative group: EORTC Lung Cancer Working Party].
    Lacroix H; Sculier JP
    Bull Cancer; 1990; 77(10):997-1005. PubMed ID: 2174277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intensive induction treatment of small cell bronchogenic carcinoma with cyclophosphamide, methotrexate, and etoposide.
    Bonomi P; O'Reilly W; Vogl SE; Ruckdeschel JC; Stolbach L; Bunting N; Creech RH
    Cancer Treat Rep; 1985 Sep; 69(9):1007-9. PubMed ID: 2992783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Controlled studies with bleomycin in solid tumors and lymphomas.
    Bonadonna G; Tancini G; Bajetta E
    Prog Biochem Pharmacol; 1976; 11():172-84. PubMed ID: 63961
    [No Abstract]   [Full Text] [Related]  

  • 19. [Etoposide. A new highly effective cytostatic agent in anaplastic small-cell bronchial carcinoma, other solid tumors and hemoblastoses].
    Goldhirsch A; Joss R; Cavalli F; Sonntag RW; Ryssel HJ; Brunner KW
    Dtsch Med Wochenschr; 1981 Aug; 106(35):1105-9. PubMed ID: 6266800
    [No Abstract]   [Full Text] [Related]  

  • 20. [Chemically-induced paraneoplastic hyperleukocytic lung].
    Le Guen Y; Lebeau B
    Rev Mal Respir; 1999 Dec; 16(6):1139-41. PubMed ID: 10637912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.